Spezielle Infektionen

  • Michael Fresenius
  • Michael Heck


Sekundäre Besiedelung des Katheters (keine klinische Relevanz).


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Ausgewählte Literatur

  1. Barth R (2010). Hohe Erfolgsrate bei schwer kranken Patienten mit Candidamie. Kongressbericht von der 44. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e.V. Tagung. Klinikarzt 10/2010.Google Scholar
  2. Bartlett JG, Perl TM (2005) The new clostridium diffice – what does it mean? N Engl J Med 353: 2503–2505PubMedCrossRefGoogle Scholar
  3. Battegay M, Flückiger U (2003) Therapie schwerer Pilzinfektionen. Internist 44: 1549–1556PubMedCrossRefGoogle Scholar
  4. Beekmann SE (1999) Unfinished business: Assessing the efficacy of extraluminal silver ions on the prevention of microbial colonization and catheter-associated infection. Critical Care Medicine 27:456–458PubMedCrossRefGoogle Scholar
  5. Begg et al. (1999) Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. J Infect 39:1–15PubMedCrossRefGoogle Scholar
  6. Böhme A, Ruhnke M, Bushheidt D, Cornely OA et al. Treatmenz of invasive fungal infections in cancer patients – recommendations of the infectious diseases working party (AGIHO) of the German Society of Hematology and oncology (DGHO) (2008) Ann Hematol 88: 97–110PubMedCrossRefGoogle Scholar
  7. Cornely OA, Maertens J, Winston DJ et al (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348–359PubMedCrossRefGoogle Scholar
  8. Daum RS et al. (2001) Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall. Critical Care Medicine 29 (Suppl):92–96CrossRefGoogle Scholar
  9. De Gans J, van de Beek D (2002) The European Dexamethasone in adulthood bacterial meningitis study investigation. New Engl J Med 347:1549PubMedCrossRefGoogle Scholar
  10. Drew RH, Arthur RR, Perfect JR (2005) Is it time to abandon the use of Amphotericin B bladder irrigation? Clin Infect Dis 40: 1465–1470PubMedCrossRefGoogle Scholar
  11. Eckmanns T (2004) Hygienische Maßnahmen bei MRSA. J Anästhesie Intensivbehandlung 2:26Google Scholar
  12. Eggimann P et al. (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27:1066–1072PubMedCrossRefGoogle Scholar
  13. Engel C et al. (2007) Intensive Care Med; 33: 606–18PubMedCrossRefGoogle Scholar
  14. Epidemiologieches Bulletin vom Robert-Kock-Institut (RKI) 2004; Nr. 46Google Scholar
  15. Empfehlungen zur Prävention und Kontrolle von methicillinresistenten Staphylococcus aureus (MRSA)-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen (1999) Bundesgesundheitsblatt 42:954–958CrossRefGoogle Scholar
  16. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2009 im InternetGoogle Scholar
  17. Fridkin SK et al. (2005) Methicillin-resistant Staphylococcus aureus disease in three communities. NEJM 352: 1436–44PubMedCrossRefGoogle Scholar
  18. Geffers C et al. (2004) Microbiological isolates associated with nosocomial infections in intensive care units: data of 274 intensive care units participating in the German Nosocomial Infections Surveillance System (KISS). Anasthesiol Intensivmed Notfallmed Schmerzther 39: 15–19PubMedCrossRefGoogle Scholar
  19. Geldner G et al. (1999) Therapie und Prophylaxe bei MRSA-Infektion auf Intensivstationen. Intensivmedizin 36:612–618CrossRefGoogle Scholar
  20. Gonzalez P et al. (1999) Reduction of catheter-associated central line sepsis in a burn unit: A new methode of catheter care. Crit Care Med 27 (Suppl): 140ACrossRefGoogle Scholar
  21. Guery BP, Arendrup MC, Auzinger G et al (2009). Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment. Intensive Care Med 35:206-214PubMedCrossRefGoogle Scholar
  22. Heizmann WR et al. (2004) Vademecum Infektiologie 2003/2004. Wyeth GmbH, MünsterGoogle Scholar
  23. Herbrecht et al. for the Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group (2002) Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis. New Engl J Med 347:408-415PubMedCrossRefGoogle Scholar
  24. Herbrecht R, Denning DW, Patterson TF et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415PubMedCrossRefGoogle Scholar
  25. Klamareck K, Rosenthal E (2005) Therapie häufiger Infektionen in der täglichen Praxis. Eine Anleitung. Klinikarzt 34: 6Google Scholar
  26. Kluge S (2009). Pilzinfektionen auf der Intensivstation. Lunch-Symposium. 41. Jahrestagung der Deutschen Gesellschaft fur internistische Intensivmedizin und Notfallmedizin. Hamburg 10.-13. Juni 2009Google Scholar
  27. Koch S et al. (2005) Diagnostik und Therapie invasiver Pilzinfektionen auf der Intensivstation. Anaesthesist 54: 1047–1066PubMedCrossRefGoogle Scholar
  28. Leon C, Ruiz-Santana S, Saavedra P et al (2009) Usefulness of the »Candida score« for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633PubMedCrossRefGoogle Scholar
  29. Lichtenstein C et al (2010). Update: Invasive Pilzinfektion. Diagnose und Therapie in der operativen Intensivmedizin. Der Anasthesist 2010; 59:30–52.CrossRefGoogle Scholar
  30. Linder MW et al. (1987) Der Mannheimer Peritonitis-Index. Ein Instrument zur intraoperativen Prognose der Peritonitis. Chirurg 58:84–92PubMedGoogle Scholar
  31. Lode M, Reiner CR. (2004) Therapie der Osteomyelitis Zeitschrift für Chemotherapie 25: 33–36Google Scholar
  32. Loo VG et al. (2005) A predominantly clonal multi-institutional outbreak of clostridium difficile-associated diarrhea with high morbidity and mortality. New Engl J Med 353: 2442–2449PubMedCrossRefGoogle Scholar
  33. Maertens J, Theunissen K, Verhoef G et al (2005). Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infec tion: a prospective feasibility study. Clin Infect Dis 41:1242–1250PubMedCrossRefGoogle Scholar
  34. Maki DG, Weise CE, Sarafin HW (1977). A semiquantitave culture method of identifying intravenous-catheter-related infection. N Engl J Med 296: 1305–1309PubMedCrossRefGoogle Scholar
  35. Maschmeyer G, Ruhnke M (2002) Arzneimitteltherapie invasiver Candida- und Aspergillusinfektionen. Internist 43: 1464–1476PubMedCrossRefGoogle Scholar
  36. McDonald LC et al. (2005) An epidemic, toxin gene-variant strain of clostridium difficile.New Engl J Med 353: 2433–2441PubMedCrossRefGoogle Scholar
  37. McGee DC et al. (2003) Preventing complications of central venous catheterization. New Engl J Med 348:1123–1133PubMedCrossRefGoogle Scholar
  38. Meersseman W, Lagrou K, Maertens J et al (2008) Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177:27–34PubMedCrossRefGoogle Scholar
  39. Moller K et al. (2000) Guidelines for managing acute bacterial meningitis. BMJ 320:1290PubMedCrossRefGoogle Scholar
  40. Mora-Duarte J for the Caspofungin Invasive Candidiasis Study Group (2002) Comparison of caspofungin and amphotericin b for invasive candidiasis. New Engl J Med 347:2020–2029PubMedCrossRefGoogle Scholar
  41. Morrell M., Fraser V.J., Kollef M.H. (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother.;49 :3640–45.PubMedCrossRefGoogle Scholar
  42. Pappas PG et al (2009) Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the infectious diseases Society of America. Clinical Infect Dis 2009; 48: 503–535CrossRefGoogle Scholar
  43. Pappas PG, Rotstein CM, Betts RF et al (2007) Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 45:883–893PubMedCrossRefGoogle Scholar
  44. Parkins MD, Sabuda DM, Elsayed S, Laupland KB (2007) Adequacy of emperial antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60: 613–8PubMedCrossRefGoogle Scholar
  45. Pascual A, Calandra T, Bolay S et al (2008) Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 46:201–211PubMedCrossRefGoogle Scholar
  46. Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in criti cally ill surgical patients. Ann Surg 220:751–758PubMedCrossRefGoogle Scholar
  47. Quagliarello V et al. (1997) Treatment of bacterial meningitis. N Engl J Med 336:708–716PubMedCrossRefGoogle Scholar
  48. Quintel M et al. (2003) Infektionskrankheiten in der Intensivmedizin, 1. Aufl. Uni-Med-Verlag, BremenGoogle Scholar
  49. Reboli AC, Rotstein C, Pappas PG et al (2007) Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med 356:2472–2482PubMedCrossRefGoogle Scholar
  50. Rimek D (2005) Wertigkeit des Aspergillus-Galaktomannan- Antigen-Nachweises zur Diagnostik invasiver Aspergillosen. Mikrobiologe 2: 72Google Scholar
  51. Robert-Koch-Institut. Empfehlungen der Kommission fur Krankenhaushygiene und Infektionspravention
  52. Senn L, Robinson JO, Schmidt S et al (2008) 1,3-Beta-Dglucan antigenemia for early diagnosis of invasive fungal infections in neutropenic pati ents with acute leukemia. Clin Infect Dis 46:878–885PubMedCrossRefGoogle Scholar
  53. Trunkel AR, Scheid WM (2002) Editorial: Corticoid for everyone with meningitis? New Engl J Med 347:1613CrossRefGoogle Scholar
  54. Ullmann AJ, Lipton JH, Vesole DH et al (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356:335–347PubMedCrossRefGoogle Scholar
  55. Wacha H et al. (2000) Antibiotikatherapie bei Peritonitis. J Anasthesie Intensivmed 1:223–226Google Scholar
  56. Walsh TJ (2002) Echinocandins – An advance in the primary treatment of invasive candidiasis. New Engl J Med 347:2070–2072PubMedCrossRefGoogle Scholar
  57. Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360PubMedCrossRefGoogle Scholar
  58. Walsh TJ for the National Institute of Allergy and Infectious Diseases Mycoses Study Group (2002) Voriconazole compared with liposomal Amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. New Engl J Med 346:225–234PubMedCrossRefGoogle Scholar
  59. Wernitz Martin Henning (2006). Screening bei stationarer Aufnahme von Risikopatienten für die Kolonisation oder Infektion mit Methicillin-resistentem Staphylococcus aureus (MRSA). Eine Kohortenstudie über den Einfluss des Screenings auf die Häufigkeit nosokominaler MRSA-Infektionen mit einer Kostenanalyse vor dem Hintergrund des deutschen DRG-Fallpauschalen-Vergutungssystems.
  60. Wernitz MH (2005). Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. Clinical Microbiol Infect, 11:457–465CrossRefGoogle Scholar
  61. Wernitz MH (2005). Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clinical Microbiol Infect, 11: 466–471CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Michael Fresenius
    • 1
  • Michael Heck
    • 2
  1. 1.Chefarzt der Klinik für Anästhesie und IntensivmedizinMarienhaus Klinikum Bendorf-Neuwied-WaldbreitbachNeuwied
  2. 2.Facharzt für Anästhesiologie – ambulante Narkosen –Heidelberg

Personalised recommendations